NOTCH3 protein levels identified idiopathic pulmonary arterial hypertension with over 90% accuracy, showing its potential as ...
A collaborative study from the MRC Laboratory of Medical Sciences (LMS) and Imperial College London has found that the protein ACE2 may play a ...
Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as the largest population-based assessment of the condition’s ...
Finding the perfect early screening test for cancer remains a persistent challenge for the health industry. But new findings suggest that blood tests still being assessed are showing promising results ...
Hot off the trail of National Breast Cancer Month in October, one company is trying to ease the detection of the disease that has been projected to impact at least 316,950 women across the country in ...
Dec. 2 (UPI) --As new blood tests capable of detecting dozens of cancers in their early stages are hitting the market, disease prevention advocates say political and economic momentum is building for ...
There’s new progress in the battle against Alzheimer’s disease. About 1 in 9 US seniors has Alzheimer’s, the most common form of dementia, which slowly impairs memory, thinking skills and the ability ...
In the spring of 2021, the cancer field was abuzz over research that suggested a simple early-detection blood test could find dozens of different cancers, including many for which there is no routine ...
The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...
A new test may get to the heart of your dementia risk several years before any symptoms emerge. Dementia, which affects over 6 million Americans, impacts memory, language and problem-solving skills.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results